In our current study, HO-1 immunoreactivity was shown early and significantly increased in NeuN immunoreactive pyramidal neurons and GFAP immunoreactive astrocytes in CA1–3 of the Hyper + ischemia group when compared with that in the Normo + ischemia group. This evidence concerns the gene HMOX1 and ischemia.